Proscia

Rewiring pathology for precision medicine

Proscia was founded in 2014, is headquartered in Philadelphia, United States, lists 51–200 employees, and has $118.3M in recorded funding across 4 rounds.

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$118.3M
Last Round
$50.0M Series CMar 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

Proscia is a Philadelphia-based digital pathology software company founded in 2014 by David West, Coleman Stavish, and Nathan Buchbinder. The company's Concentriq platform is an enterprise digital pathology system used by more than 12,000 pathologists and scientists daily at reference labs, academic medical centers, CROs, and 16 of the top 20 global pharma companies. Concentriq offers purpose-built products for life sciences research, anatomic pathology digitization, and FDA-cleared primary diagnosis. Proscia also offers Aperture, a precision medicine solution for drug development and real-world evidence generation.

Summary

Proscia is an Artificial Intelligence company based in Philadelphia, United States, founded in 2014. It lists 51–200 employees. It has raised $118.3M in total across 4 rounds, most recently a $50.0M Series C round in Mar 2025. Investors include Insight Partners, Scale Venture Partners and Triangle Peak Partners.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMar 2025
$50.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Proscia on Indexed.vc
<a href="https://indexed.vc/companies/proscia"><img src="https://indexed.vc/api/badge/company/proscia" alt="Proscia on Indexed.vc" width="260" height="76" /></a>